Table 4 Relative frequency and multivariate analysis of HPV infection in HIV- negative and HIV- positive women
HPV positive detection | ||||
|---|---|---|---|---|
n | (%)* | Adjusted OR | 95% CI | |
HIV status | ||||
Negative | 513 | (44.3) | Ref | |
Positive | 149 | (69.0) | 2.37 | 1.69-3.34 |
HIV and one type only HPV (single infection) | ||||
HIV-negative, single infection | 250 | (21.6) | Ref | |
HIV-positive, single infection | 32 | (14.8) | 1.14 | 0.85-1.28 |
HIV and >1 type HPV (multiple infection) | ||||
HIV-negative, multiple infection | 263 | (22.7) | Ref | |
HIV-positive, multiple infection | 117 | (54.2) | 3.43 | 2.39-4.92 |
HIV and HPV Clade 7 | ||||
HIV-negative, HPV Clade 7 | 202 | (17.4) | Ref | |
HIV-positive, HPV Clade 7 | 77 | (35.7) | 2.48 | 1.69-3.64 |
HIV and HPV Clade 9 | ||||
HIV-negative, HPV Clade 9 | 454 | (39.2) | Ref | |
HIV-positive, HPV Clade 9 | 141 | (65.3) | 2.47 | 1.73-3.53 |
HIV; immune status CD4 cell/mm 3 count | ||||
HIV-negative | 513 | (44.3) | Ref | |
HIV-positive, < 200 | 63 | (29.2) | 4.38 | 2.47-7.77 |
HIV-positive, 200 - 349 | 39 | (18.1) | 3.13 | 1.64-5.96 |
HIV-positive, 350 - 500 | 29 | (13.4) | 1.91 | 1.03-3.57 |
HIV-positive, > 500 | 18 | (8.3) | 1.17 | 0.59-2.32 |
HIV viral load copies/mL | ||||
HIV-negative | 513 | (44.3) | Ref | |
HIV-positive, <4,000 | 121 | (56.0) | 2.41 | 0.67-3.48 |
HIV-positive, 4,000-99,999 | 15 | (6.9) | 2.43 | 0.96-6.14 |
HIV-positive, >100,000 | 13 | (6.0) | 7.32 | 1.62-33.03 |
HIV and ART use | ||||
HIV-negative | 513 | (44.3) | Ref | |
HIV-positive, treatment with ART | 133 | (61.6) | 2.46 | 1.72-3.51 |
HIV-positive , without treatment with ART | 16 | (7.4) | 3.32 | 1.16-9.50 |